Related references
Note: Only part of the references are listed.A Modern Approach to Dyslipidemia
Amanda J. Berberich et al.
ENDOCRINE REVIEWS (2022)
Association Between Dietary Patterns and Dyslipidemia in Korean Women
Jeonghee Lee et al.
FRONTIERS IN NUTRITION (2022)
Efficacy of combination therapy with ezetimibe and statins versus a double dose of statin monotherapy in participants with hypercholesterolemia: a meta-analysis of literature
Min Yu et al.
LIPIDS IN HEALTH AND DISEASE (2020)
Changes in lipids composition and metabolism in colorectal cancer: a review
Alicja Pakiet et al.
LIPIDS IN HEALTH AND DISEASE (2019)
Effect of obesity, dyslipidemia, and diabetes on trastuzumab-related cardiotoxicity in breast cancer
P. Kosalka et al.
CURRENT ONCOLOGY (2019)
Perceived stress is associated with a higher symptom burden in cancer survivors
Melissa Mazor et al.
CANCER (2019)
Epidemiology of liver cancer in South Korea
Bo Hyun Kim et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2018)
Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors
Gregory S. Calip et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Prevalence and Clinical Characteristics of Dyslipidemia in Koreans
Jee-Sun Jeong et al.
ENDOCRINOLOGY AND METABOLISM (2017)
Network analysis of human diseases using Korean nationwide claims data
Jin Hee Kim et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2016)
Effect of diet on mortality and cancer recurrence among cancer survivors: a systematic review and meta-analysis of cohort studies
Carolina Schwedhelm et al.
NUTRITION REVIEWS (2016)
Dyslipidemia and colorectal cancer risk: a meta-analysis of prospective studies
Xu Yao et al.
CANCER CAUSES & CONTROL (2015)
Colorectal cancer risk and dyslipidemia: A case-cohort study nested in an Italian multicentre cohort
Claudia Agnoli et al.
CANCER EPIDEMIOLOGY (2014)
Decision Making About Change of Medication for Comorbid Disease at the End of Life: An Integrative Review
Ronald T. C. M. van Nordennen et al.
DRUGS & AGING (2014)
Disease management index of potential years of life lost as a tool for setting priorities in national disease control using OECD health data
Sung-In Jang et al.
HEALTH POLICY (2014)
Five-year Relative Survival Rate of Breast Cancer in the USA, Europe and Japan
Kota Katanoda et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2014)
Secondary Causes of Dyslipidemia
Deepthi Vodnala et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Health status of adolescent and young adult cancer survivors
Eric Tai et al.
CANCER (2012)
Reducing cardiovascular disease risk in medically underserved urban and rural communities
Alfred A. Bove et al.
AMERICAN HEART JOURNAL (2011)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Mortality among 5-year survivors of cancer diagnosed during childhood or adolescence in British Columbia, Canada
Amy C. MacArthur et al.
PEDIATRIC BLOOD & CANCER (2007)
Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia
Ronald M. Krauss et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2006)
A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia
RB Goldberg et al.
DIABETES CARE (2005)
Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia
ES Parris et al.
DIABETES CARE (2005)
Pharmacotherapy of dyslipidemia
JM McKenney
CARDIOVASCULAR DRUGS AND THERAPY (2001)
Share Paper
